Electrophysiological Alterations in the Progression of Parkinson's Disease and the Therapeutic Effect of Tetrabenazine on Rats With Levodopa‐Induced Dyskinesia
Tetrabenazine abrogated aberrant gamma activity to improve LID symptoms, which provides compelling evidence for its future clinical application in LID therapy.
Authors
- Zhuyong Wang (ORCID: https://orcid.org/0000-0001-5518-7923)
- Yue-Wei Bi (ORCID: https://orcid.org/0000-0001-5448-9751)
- Pengfei Wang (ORCID: https://orcid.org/0000-0003-1758-2484)
- Siyuan Lv (ORCID: https://orcid.org/0000-0002-8768-0293)
- Wangming Zhang (ORCID: https://orcid.org/0000-0003-4506-6321)
- Yong Yang (ORCID: https://orcid.org/0000-0002-9094-7868)
- Min Li (ORCID: https://orcid.org/0000-0002-7113-2700)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
- Zhujiang Hospital (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- CNS Neuroscience & Therapeutics
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1111/cns.70250
- Citations
- 1
- Primary Topic
- Neurological disorders and treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- National Natural Science Foundation of China